Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
APOBEC1 complementation factor | 0.604 | 0.692 | 5.9E-10 |
|
disease | 0.100 | None | 1.000 | 1 | 12 | 2013 | 2013 | ||||||||
|
APOBEC1 complementation factor | 0.604 | 0.692 | 5.9E-10 |
|
disease | 0.100 | None | 1.000 | 1 | 12 | 2013 | 2013 | ||||||||
|
AAR2 splicing factor | 0.839 | 0.192 | 8.3E-06 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2010 | 2010 | ||||||||
|
AAR2 splicing factor | 0.839 | 0.192 | 8.3E-06 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2010 | 2010 | ||||||||
|
apoptosis associated transcript in bladder cancer | 0.890 | 0.115 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | |||||||||
|
4-aminobutyrate aminotransferase | 0.628 | 0.538 | 6.3E-03 |
|
phenotype | 0.100 | None | 1.000 | 1 | 7 | 2013 | 2013 | ||||||||
|
ATP binding cassette subfamily A member 1 | 0.467 | 0.846 | 1.5E-13 |
|
phenotype | 0.100 | None | 1.000 | 12 | 29 | 2008 | 2019 | ||||||||
|
ATP binding cassette subfamily A member 1 | 0.467 | 0.846 | 1.5E-13 |
|
phenotype | 0.100 | None | 1.000 | 12 | 29 | 2008 | 2013 | ||||||||
|
ATP binding cassette subfamily A member 1 | 0.467 | 0.846 | 1.5E-13 |
|
phenotype | 0.100 | None | 1.000 | 3 | 21 | 2010 | 2019 | ||||||||
|
ATP binding cassette subfamily A member 1 | 0.467 | 0.846 | 1.5E-13 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2009 | 2019 | ||||||||
|
ATP binding cassette subfamily A member 1 | 0.467 | 0.846 | 1.5E-13 |
|
disease | 0.200 | None | 0.960 | 1 | 5 | 2000 | 2019 | ||||||||
|
ATP binding cassette subfamily A member 1 | 0.467 | 0.846 | 1.5E-13 |
|
disease | 0.200 | None | 0.938 | 1 | 1 | 2005 | 2019 | ||||||||
|
ATP binding cassette subfamily A member 1 | 0.467 | 0.846 | 1.5E-13 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
ATP binding cassette subfamily A member 1 | 0.467 | 0.846 | 1.5E-13 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
ATP binding cassette subfamily A member 1 | 0.467 | 0.846 | 1.5E-13 |
|
disease | 0.200 | None | 1.000 | 1 | 1 | 2005 | 2020 | ||||||||
|
ATP binding cassette subfamily A member 13 | 0.722 | 0.308 | 8.8E-114 |
|
phenotype | 0.100 | None | 1.000 | 1 | 9 | 2013 | 2013 | ||||||||
|
ATP binding cassette subfamily A member 4 | 0.493 | 0.769 | 5.3E-48 |
|
disease | 0.410 | None | 0.750 | 2 | 12 | 2010 | 2017 | ||||||||
|
ATP binding cassette subfamily A member 4 | 0.493 | 0.769 | 5.3E-48 |
|
phenotype | 0.100 | None | 1.000 | 1 | 3 | 2012 | 2012 | ||||||||
|
ATP binding cassette subfamily A member 4 | 0.493 | 0.769 | 5.3E-48 |
|
phenotype | 0.100 | None | 1.000 | 1 | 3 | 2012 | 2012 | ||||||||
|
ATP binding cassette subfamily A member 4 | 0.493 | 0.769 | 5.3E-48 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2012 | 2012 | ||||||||
|
ATP binding cassette subfamily A member 7 | 0.644 | 0.577 | 2.1E-55 |
|
disease | 0.500 | None | 0.985 | 4 | 4 | 2011 | 2019 | ||||||||
|
ATP binding cassette subfamily A member 7 | 0.644 | 0.577 | 2.1E-55 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
ATP binding cassette subfamily A member 8 | 0.821 | 0.231 | 1.6E-52 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2010 | 2019 | ||||||||
|
ATP binding cassette subfamily A member 8 | 0.821 | 0.231 | 1.6E-52 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2010 | 2013 | ||||||||
|
ATP binding cassette subfamily B member 11 | 0.566 | 0.654 | 1.6E-12 |
|
phenotype | 0.100 | None | 1.000 | 3 | 4 | 2008 | 2019 |